The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...
Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a major consumer health goods company if shareholders approve.
The purchase adds Listerine mouthwash, Band-Aid, Neutrogena, Aveeno, Benadryl, and Zyrtec to the Kimberly-Clark portfolio. Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7B deal, creating a ...
Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...
Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...